Skip to content
Recall Observatory FDA recall evidence

Drug product

Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, Rx ONLY, packaged in a) 16 fl oz (473 mL) NDC 0121-0868-16; b) 2 fl oz (60 mL) NDC 0121-0868-02; Manufactured by: Pharmaceutical Associates, Inc. Greenville, SC 29605

D-0721-2021

July 29, 2021

Class II

Product summary

Firm
PAI Holdings, LLC. dba Pharmaceutical Associates Inc
Event
Event 88392
Status
Terminated
Classification
Class II
Quantity
a) 1002 cases (12 bottles/case); b) 458 cases (24 bottles/case)
Official record key
drug-enforcement:D-0721-2021

Official wording

Reason: Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.

Code information: Lots: a) C98F, C990 Exp. 30SEP2022, C9C2 Exp. 31OCT2022; b) C9E1 Exp. 31OCT2022

Distribution pattern: Distributed Nationwide in the USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    Lack of CGMP